Richardson, Texas – (May 1, 2024) –  MedeAnalytics, a healthcare analytics software-as-a-service (SaaS) leader enabling clinical, financial and operational analytics, announced today the appointment of Katie O’Connell to chief business development officer. O’Connell is a seasoned executive with a passion for driving strategic growth and fostering innovation. In her new role, she will leverage her deep experience in strategic consulting, combined with MedeAnalytics’ leading-edge innovation in the industry, to deliver key results for clients across all aspects of the healthcare continuum.

 

“With Katie’s exemplary leadership skills and results-driven mindset, we are excited to have her leading our business development needs during this time of unprecedented innovation at MedeAnalytics,” said Steve Grieco, chief executive officer of MedeAnalytics. “Katie brings a unique blend of expertise in business development, strategic partnerships, and market expansion. Her track record of identifying and capitalizing on emerging opportunities has been instrumental in driving profitable revenue growth and market penetration, and she’ll play a key role in supporting additional growth for us here at MedeAnalytics. We are thrilled to have her join our executive leadership team.”

 

Prior to joining MedeAnalytics, Katie was a Senior Managing Director at AArete, a healthcare consulting firm that she co-founded and served in key leadership roles. Throughout her career, she has continued to successfully lead cross-functional teams to execute on ambitious growth initiatives. Her collaborative leadership style, coupled with her ability to navigate complex business landscapes, has earned her a reputation as a trusted advisor and results-driven leader.

 

Outside of the boardroom, Katie is a strong advocate for making a positive impact on both individuals and communities. She actively engages in initiatives aimed at fostering diversity and inclusion and is passionate about leveraging business as a force for good.

 

“I’m excited to join MedeAnalytics during such a time of growth and innovation,” said O’Connell. “The team at MedeAnalytics is dedicated to strategic growth, cultivating strong relationships with its clients and partners, and is deeply committed to making an impact in healthcare. With an already seasoned leadership team in place, I’m looking forward to contributing with my experience and expertise to help move MedeAnalytics forward.”

 

Katie holds an MBA from the University of Notre Dame and is committed to team building, continuous learning, and professional development.